Alpha 2 Antiplasmin, Human Plasma recombinant protein
Alpha-2-plasmin inhibitor, SERPINF2, AAP, PLI
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P08697 |
---|---|
Calculated MW | 70 kDa |
Gene ID | 5345 |
---|---|
Gene Symbol | SERPINF2 |
Other Names | Alpha-2-plasmin inhibitor, SERPINF2, AAP, PLI |
Gene Source | Human |
Source | Human Plasma |
Assay&Purity | SDS-PAGE; ≥95% |
Assay2&Purity2 | N/A; |
Recombinant | No |
Target/Specificity | SERPINF2 |
Application Notes | In water or aqueous buffer |
Format | Lyophilized |
Storage | -20°C; Lyophilized from 20 mM Bis-Tris, pH 6.4, with 200 mM NaCl. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Alpha 2 Antiplasmin is a member of the Serpin superfamily and the primary physiological inhibitor of the serine protease plasmin, which is responsible for the dissolution of fibrin clots. In addition to plasmin, it is also an efficient inhibitor of trypsin and chymotrypsin. Liver and kidney are major sites of its production and other tissues such as muscle, intestine, central nervous system, and placenta also express its mRNA at a moderate level. The tissue expression pattern indicates that it is a key regulator of plasmin mediated proteolysis in these tissues. Alpha-Antiplasmin-deficiency is a rare coagulation disorder which allows unrestrained fibrinolytic activity. Individuals with this condition may receive therapeutic A2AP prior to surgery to prevent postoperative hemorrhaging.
References
Tone M.,et al.J. Biochem. 102:1033-1041(1987).
Hirosawa S.,et al.Proc. Natl. Acad. Sci. U.S.A. 85:6836-6840(1988).
Hirosawa S.,et al.Proc. Natl. Acad. Sci. U.S.A. 86:1612-1613(1989).
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Zody M.C.,et al.Nature 440:1045-1049(2006).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.